Visiongain Report Offers Transformative Insights on $38bn Respiratory Inhalers Market

Thursday, October 25, 2018 Respiratory Disease News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, October 25, 2018 /PRNewswire/ --

Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others

 

The global respiratory inhalers market reached $33bn in 2017 and is estimated to reach $38bn by 2023. In 2017, the asthma segment held 58% of the global respiratory inhalers

market.

     (Logo: https://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 165-page report you will receive 121 charts- all unavailable elsewhere.

The 165-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Respiratory Inhalers Market from 2018-2028

• Forecast of the Global Respiratory Inhalers market by Type of Product: • Metered Dose Inhalers (MDIs) • Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs • Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers

• Forecast of the Global Respiratory Inhalers market by Indication: • Asthma • COPD • Other Respiratory Diseases

• This report provides individual revenue forecasts to 2028 for these national markets: • The US • Germany • France • UK • Italy • Spain • Japan • China • India • Russia • Brazil • Mexico • Canada

• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market: • AstraZeneca • Boehringer Ingelheim • Chiesi Farmaceutici S.p.A. • GlaxoSmithKline (GSK) • Merck & Co. • Novartis • Teva

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the Porter's Five Forces Analysis of the respiratory inhalers market.

Visiongain's study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/the-global-respiratory-inhalers-market-2018-2028/

3M Drug Delivery Systems Actavis Adherium Limited Aerogen Agilent Technology Airssential Allied Healthcare Almirall Astrazeneca Boehringer Ingelheim Briggs Healthcare CareFusion Chiesi Circassia Pharmaceuticals plc Cipla Clement Clarke International Cohero Health DeVilbiss Healthcare Fexicare Gecko Health Innovations GF Health Products GlaxoSmithKline Heyer Medical Hikma IBM Watson Health Innovate Biomed Innoviva Inspiro Medical Mabis Healthcare Medline Surgical Merck MRK Healthcare Mylan Nexus 6 Nouvag AG Novartis Omron Healthcare Opko Health Orion Pharma PARI Medical Pfizer Philips Respironics Propeller Health Qualcomm Incorporated Roche Schering-Plough Sunovion Pharma Takeda Pharmaceutical Company Limited Teva Pharmaceuticals Theravance Vectura Viatris List of Organizations Mentioned in the Report British Lung Foundation Centers for Disease Control and Prevention Centre for Devices and Radiological Health European Databank on Medical Devices European Medicines Agency European Respiratory Society Food and Drug Administration German Ministry of Health Global Initiative for Asthma Global Initiative for Chronic Obstructive Lung Disease IBM Watson Health Kaohsiung Medical University Ministry of Health, Labour and Welfare Mount Sinai Hospital MRC Technology ServicioSanitarioNazionale UK NHS US National Heart, Lung, and Blood Institute US National Institutes of Health Weill Cornell Medicine World Health Organization (WHO)

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store